$44
$8.80/mg
-26% vs median/mg
Availability
In stock
Last checked
36 minutes ago
A synthetic long-acting analog of the pancreatic hormone amylin.
Observed median price
$89
11
Active listings
2 · 99.8%
Independent lab tests
$44–$140
Observed price range
4
Known aliases
Read from the certificate, not re-measured by VialGrade.
Understand this compound
An amylin analog studied in weight research, often discussed alongside semaglutide ('CagriSema').
Good to know: Most efficacy and safety data come from the CagriSema combination rather than cagrilintide alone; standalone long-term human safety data are limited.
A long-acting amylin receptor agonist; activates amylin/calcitonin receptors to slow gastric emptying and enhance satiety, complementing GLP-1 signaling.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
Studied mainly in combination with semaglutide (as CagriSema) for enhanced obesity/weight management and type-2 diabetes.
In clinical trials; Phase 3 (REDEFINE) complete for the CagriSema combination, which was under FDA review as of 2026, but not yet approved as a standalone drug.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
Investigational drug — not approved, under FDA scrutiny
This is an investigational amylin analog still in trials. It has no FDA approval for any use, is not a supplement, and the FDA is actively watching the GLP-1-class “research” market. Sold research-use-only; marketing or using it as a drug is not lawful.
Read the full US legal overview →General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Compare by real cost
Vials come in different sizes, so the sticker price lies. This ranks every listing by what a milligram actually costs — with independent test purity where we have it.
| # | Vendor | Size | Price | Per mg | Tested purity | Real $/active mg | |
|---|---|---|---|---|---|---|---|
| 1 | Ez Peptides | 5mg total | $44 | $8.80/mg | — | $8.82/mgbest value | View |
| 2 | Ez Peptides | 10mg total | $88 | $8.80/mg | — | $8.82/mg | View |
| 3 | Bluum Peptides | 10mg total | $89 | $8.90/mg | — | $8.92/mg | View |
| 4 | Ez Peptides | 12.5mg total | $118 | $9.44/mg | — | $9.46/mg | View |
| 5 | Bluum Peptides | 5mg total | $59 | $11.8/mg | — | $11.8/mg | View |
| 6 | Modern Aminos | 10mg total | $119 | $11.9/mg | — | $11.9/mg | View |
| 7 | Umbrella Labs | 10mg total10 Milligrams Vial each | $130 | $13.0/mg | — | $13.0/mg | View |
| 8 | Simple Peptide | 10mg total | $140 | $14.0/mg | — | $14.0/mg | View |
| 9 | Modern Aminos | 8mg total | $117 | $14.6/mg | — | $14.7/mg | View |
| 10 | Umbrella Labs | 5mg total | $80 | $16.0/mg | — | $16.0/mg | View |
Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg.
Current market
$44
$8.80/mg
-26% vs median/mg
Availability
In stock
Last checked
36 minutes ago
$59
$11.8/mg
Availability
In stock
Last checked
8 days ago
$78
Availability
In stock
Last checked
2 hours ago
$80
$16.0/mg
+35% vs median/mg
Availability
In stock
Last checked
1 hour ago
$88
$8.80/mg
-26% vs median/mg
Availability
In stock
Last checked
36 minutes ago
$89
$8.90/mg
-25% vs median/mg
Availability
In stock
Last checked
8 days ago
$117
$14.6/mg
+23% vs median/mg
Availability
In stock
Last checked
1 hour ago
$118
$9.44/mg
-20% vs median/mg
Availability
In stock
Last checked
36 minutes ago
$119
$11.9/mg
Availability
In stock
Last checked
1 hour ago
$130
$13.0/mg
+10% vs median/mg
Availability
In stock
Last checked
1 hour ago
$140
$14.0/mg
+18% vs median/mg
Availability
In stock
Last checked
2 hours ago
Commonly researched together
Compounds the research community frequently discusses alongside Cagrilintide. Not a protocol or a recommendation — a starting point for what to read about next.
Independent testing
Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.
Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.
Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.
We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.
Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.
Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.
99.9%
highest tested purity
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.